Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 28.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
28.02.Alzinova AB: Alzinova publishes Year-end report 202375The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the year-end report for the period January - December 2023. Three months, October - December 2023Net sales amounted...
► Artikel lesen
28.02.Scandion Oncology A/S: Scandion Oncology - Q4 & yearend report 2023115Scandion Oncology (Scandion) today announces its Q4 & yearend report 2023. The following is taken from the report. Francois Martelet, CEO:"Completion of and very positive topline results from part 3...
► Artikel lesen
28.02.Lipidor AB: Lipidor AB (publ) publishes year-end report for 2023105STOCKHOLM, Sweden, 28th February 2024 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2023. The report is available...
► Artikel lesen
28.02.Royal Helium Ltd.: Royal Helium Announces 2024 Development Plan79SASKATOON, SK, Feb. 28, 2024 /CNW/ - Royal Helium Ltd. (TSXV: RHC) (TSXV: RHC.WT.A) (OTCQB: RHCCF) ("Royal" or the "Company") is pleased to announce its initial set of development plans for 2024....
► Artikel lesen
28.02.Diagonal Bio AB: Diagonal Bio AB Year-end Report 202397"Looking back at 2023, I am proud to point out the significant steps we have made in our development, including the key achievements such as the CE-marking of LAMPlify® according to Low Voltage Directive...
► Artikel lesen
28.02.Diagonal Bio AB: Diagonal Bio appoints Karin Wehlin as new CEO93Diagonal Bio AB (publ.) ("Diagonal Bio" or "the Company") is pleased to announce that the Board of Directors has appointed Karin Wehlin as Chief Executive Officer (CEO) of Diagonal Bio. Karin Wehlin...
► Artikel lesen
28.02.DelfinGroup: DelfinGroup revenue increased by 41% in 2023164Last year, Latvian fintech company DelfinGroup continued to increase its growth rates in all business segments, focusing on developing circulation of pre-owned goods and introducing innovative solutions....
► Artikel lesen
28.02.TUI: Reisefieber?287Etwas rätselhaft ist aktuell der Verlauf der Aktie von TUI für den Markt. Die Notierungen sind am Mittwoch um gut -0,6 % nach unten durchgereicht worden. Das ist angesichts der relativen Stabilität...
► Artikel lesen
28.02.Vonovia-Aktie: Immobilien-Krise?181Vonovia ist als Wohnungsbauunternehmen zumindest in weiten Teilen von der Immobilien-"Krise" in Deutschland betroffen. Das zeigt sich auch an Tagen wie dem Mittwoch, als die Aktie gleich -2,7 % verlor....
► Artikel lesen
28.02.Enerflex Ltd. Reports Fourth Quarter 2023 Financial and Operational Results185ADJUSTED EBITDA OF $126 MILLION AND $185 MILLION OF FREE CASH FLOW ENGINEERED SYSTEMS BACKLOG OF $1.5 BILLION PROVIDES SOLID VISIBILITY FOR 2024 REPAID $167 MILLION OF DEBT AND REDUCED NET DEBT-TO-EBITDA...
► Artikel lesen
28.02.Cytek Biosciences, Inc.: Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook272FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results...
► Artikel lesen
28.02.Portage Biotech Inc.: Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update176WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company"), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies...
► Artikel lesen
28.02.WSP Global Inc.: WSP Reports Strong 2023 Results and Outlook for 20242042023 ACCOMPLISHMENTS: Strong results in the high end of Management's revised outlook rangeNet revenue up 22% or nearly $2B resulting from strong organic growth of 7.3% and strategic acquisitionsAdjusted...
► Artikel lesen
28.02.CymaBay Therapeutics, Inc.: CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update174Gilead Sciences, Inc. has proposed to acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. U.S. FDA accepted seladelpar NDA for priority review, and seladelpar...
► Artikel lesen
28.02.Aimfinity Investment Corp. I Announces Eighth Extension of the Deadline for an Initial Business Combination to March 28, 202434Wilmington, Delaware, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the "Company" or "AIMA") (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands...
► Artikel lesen
28.02.Marathon Digital Holdings Inc.: Marathon Digital Holdings Reports Fourth Quarter and Fiscal Year 2023 Results323- Revenues Increase 229% to a Record $388 Million in 2023- Net Income Improves to $261.2 Million, or $1.06 per Diluted Share, in 2023- Adjusted EBITDA Improves to $419.9 Million in 2023- BTC...
► Artikel lesen
28.02.Premier Products Group, Inc.: Premier Products Group Issues Shareholder Letter194BREMERTON, Wash., Feb. 28, 2024 (GLOBE NEWSWIRE) -- via IBN -- Premier Products Group, Inc. (OTC: PMPG) today issued a letter to shareholders from Terry L Stein, Interim CEO. Dear shareholders, We...
► Artikel lesen
28.02.Societal CDMO, Inc.: Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.341Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx...
► Artikel lesen
28.02.Havila Kystruten AS: Fourth quarter 2023 accounts410Summary The company has completed its first quarter with full operation of all four ships. Revenue in the fourth quarter was MNOK 249. Due to late clarification on the delivery of the last two...
► Artikel lesen
28.02.HP Inc. Reports Fiscal 2024 First Quarter Results196PALO ALTO, Calif, Feb. 28, 2024 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) First quarter GAAP diluted net earnings per share ("EPS") of $0.62, within the previously provided outlook of $0.60 to $0.70 per...
► Artikel lesen
Seite:  Weiter >>